Conde Délio Marques, Pinto-Neto Aarão Mendes, Costa-Paiva Lúcia
Department of Gynecology and Obstetrics, Universidade Federal de Goiás, Goiânia, Goíás, Brazil.
Gynecol Endocrinol. 2008 Feb;24(2):84-6. doi: 10.1080/09513590701806870.
The advent of highly active antiretroviral therapy has promoted a reduction in mortality due to HIV. Thus more women are living longer after receiving a diagnosis of HIV infection. With an increase in survival, topics related to the menopausal transition in HIV-infected women have emerged, such as age at menopause, bone mineral density and menopause-related symptoms. To this end, several studies have investigated age at menopause (AM) in HIV-infected women. The present paper reviews these studies and discusses the possible clinical implications of determining AM for HIV-positive women.
高效抗逆转录病毒疗法的出现促使因艾滋病病毒（HIV）导致的死亡率有所下降。因此，更多女性在被诊断出感染HIV后寿命得以延长。随着生存期的延长，与HIV感染女性绝经过渡相关的话题逐渐浮现，比如绝经年龄、骨密度以及绝经相关症状。为此，多项研究对HIV感染女性的绝经年龄进行了调查。本文对这些研究进行综述，并探讨确定HIV阳性女性绝经年龄可能具有的临床意义。
